{
  "issued_date": "2012-10-25", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON197918", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2012/075", 
    "Audience": "Healthcare professionals", 
    "Published": "25 October 2012 at 12:00", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [], 
  "body": "## Device\n\nAll medical devices and medicinal products containing chlorhexidine.\n\nA variety of medicinal products and medical devices contain chlorhexidine, including some over-the-counter (OTC) products.\n\nThe MHRA does not hold a comprehensive list of products containing chlorhexidine. However, examples of products which contain chlorhexidine are: antiseptic creams, wipes, cleansers and skin preparations; antiseptic mouthwashes, toothpastes and dental implants; eye drops and contact lens solutions; antiseptic lozenges and throat sprays; urinary catheters; central venous catheters; and antimicrobial dressings.\n\n## Problem\n\nRisk of anaphylactic reaction due to chlorhexidine allergy.\n\nThe MHRA has received a number of reports of anaphylactic reactions following the use of products containing chlorhexidine. Two examples are given below:  \n  \n  * a patient had an anaphylactic reaction when a skin wipe that contained chlorhexidine gluconate was used prior to cannulation. The patient had previously had an anaphylactic reaction whilst under general anaesthetic but at the time the cause of the reaction was unknown.  \n  * it was reported that a patient with a known chlorhexidine allergy, which was noted on his file and on his wristband, suffered a cardiac arrest shortly after a chlorhexidine impregnated central venous catheter was inserted whilst in the operating theatre. He was successfully resuscitated.  \n  \nThere are also other reports of allergic reactions to chlorhexidine published in journals.\n\n## Action  \n  \n  * Be aware of the potential for an anaphylactic reaction to chlorhexidine.  \n  * Ensure that known allergies are recorded in patient notes.  \n  * Check the labels and instructions for use to establish if products contain chlorhexidine prior to use on patients with a known allergy.  \n  * If a patient experiences an unexplained reaction, check whether chlorhexidine was used or was impregnated in a medical device that was used.  \n  * Report allergic reactions to products containing chlorhexidine to the MHRA.  \n  * Further guidance on anaphylaxis is available from [NICE](http://guidance.nice.org.uk/CG134/Guidance/pdf/English), the [Resuscitation Council](http://www.resus.org.uk/pages/reaction.htm)and the [AAGBI](http://www.aagbi.org/safety/allergies-and-anaphylaxis).  \n  \n### Action by\n\nAll medical and nursing staff involved in the use of these devices and medicinal products.\n\n## Distribution\n\nThis MDA has been sent to:  \n  \n  * NHS trusts in England (chief executives)  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * Local authorities in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * A&E departments  \n  * All clinical staff  \n  * All departments  \n  * All surgical units  \n  * All wards  \n  * Anaesthetists  \n  * Clinical governance leads  \n  * Dentists  \n  * Haemodialysis units  \n  * Immunologists  \n  * Infection prevention & control directors  \n  * Infection prevention & control teams  \n  * Intensive care units  \n  * IV nurse specialists  \n  * Medical directors  \n  * Medical oncologists  \n  * Nursing executive directors  \n  * Obstetrics and gynaecology departments  \n  * Ophthalmology departments  \n  * Paramedics  \n  * Pharmacists  \n  * Phlebotomists  \n  * Renal medicine departments  \n  * Resuscitation officers and trainers  \n  * Risk managers  \n  * Supplies managers  \n  * Surgeons  \n  * Theatre managers  \n  * Urology departments  \n  \nPrimary care trusts  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * Community dental practices  \n  * Community hospitals  \n  * Community midwives  \n  * Community nurses  \n  * Community pharmacists  \n  * General dental practitioners  \n  * General practitioners  \n  * Minor injury units  \n  * NHS walk-in centres  \n  * Ophthalmic practices  \n  * Optometrists  \n  * Practice managers  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Care homes providing nursing care  \n  * Clinics  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Nursing agencies  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2012/075 or 2012/010/003/081/016\n\nTechnical aspects  \nSharon Knight or Louise Mulroy  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0020 3080 7202 / 7344  \nFax:\u00a0020 8754 3965  \nEmail:\u00a0 [sharon.knight@mhra.gsi.gov.uk](mailto:sharon.knight@mhra.gsi.gov.uk) or [louise.mulroy@mhra.gsi.gov.uk](mailto:louise.mulroy@mhra.gsi.gov.uk)\n\nClinical aspects  \nJonathan Plumb  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0020 3080 6648  \nFax:\u00a0020 8754 3965  \nEmail:\u00a0 [jonathan.plumb@mhra.gsi.gov.uk](mailto:jonathan.plumb@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span>All medical devices and medicinal products containing chlorhexidine.</span></p>\n\n<p>A variety of medicinal products and medical devices contain chlorhexidine, including some over-the-counter (OTC) products.</p>\n\n<p>The MHRA does not hold a comprehensive list of products containing chlorhexidine. However, examples of products which contain chlorhexidine are: antiseptic creams, wipes, cleansers and skin preparations; antiseptic mouthwashes, toothpastes and dental implants; eye drops and contact lens solutions; antiseptic lozenges and throat sprays; urinary catheters; central venous catheters; and antimicrobial dressings.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Risk of anaphylactic reaction due to chlorhexidine allergy.</span></p>\n\n<p>The MHRA has received a number of reports of anaphylactic reactions following the use of products containing chlorhexidine. Two examples are given below:</p>\n\n<ul type=\"disc\">\n<li>a patient had an anaphylactic reaction when a skin wipe that contained chlorhexidine gluconate was used prior to cannulation. The patient had previously had an anaphylactic reaction whilst under general anaesthetic but at the time the cause of the reaction was unknown.</li>\n</ul>\n\n<ul type=\"disc\">\n<li>it was reported that a patient with a known chlorhexidine allergy, which was noted on his file and on his wristband, suffered a cardiac arrest shortly after a chlorhexidine impregnated central venous catheter was inserted whilst in the operating theatre. He was successfully resuscitated.</li>\n</ul>\n\n<p>There are also other reports of allergic reactions to chlorhexidine published in journals.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\n<li>Be aware of the potential for an anaphylactic reaction to chlorhexidine.</li>\n\n<li>Ensure that known allergies are recorded in patient notes.</li>\n\n<li>Check the labels and instructions for use to establish if products contain chlorhexidine prior to use on patients with a known allergy.</li>\n\n<li>If a patient experiences an unexplained reaction, check whether chlorhexidine was used or was impregnated in a medical device that was used.</li>\n\n<li>Report allergic reactions to products containing chlorhexidine to the MHRA.</li>\n\n<li>Further guidance on anaphylaxis is available from <a href=\"http://guidance.nice.org.uk/CG134/Guidance/pdf/English\" target=\"blank\">NICE</a>, the <a href=\"http://www.resus.org.uk/pages/reaction.htm\" target=\"blank\">Resuscitation Council</a>and the <a href=\"http://www.aagbi.org/safety/allergies-and-anaphylaxis\" target=\"blank\">AAGBI</a>.</li>\n</ul>\n\n<h3>Action by</h3>\n\n<p>All medical and nursing staff involved in the use of these devices and medicinal products.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>NHS trusts in England (chief executives)</li>\n\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>Local authorities in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>A&amp;E departments</li>\n\n<li>All clinical staff</li>\n\n<li>All departments</li>\n\n<li>All surgical units</li>\n\n<li>All wards</li>\n\n<li>Anaesthetists</li>\n\n<li>Clinical governance leads</li>\n\n<li>Dentists</li>\n\n<li>Haemodialysis units</li>\n\n<li>Immunologists</li>\n\n<li>Infection prevention &amp; control directors</li>\n\n<li>Infection prevention &amp; control teams</li>\n\n<li>Intensive care units</li>\n\n<li>IV nurse specialists</li>\n\n<li>Medical directors</li>\n\n<li>Medical oncologists</li>\n\n<li>Nursing executive directors</li>\n\n<li>Obstetrics and gynaecology departments</li>\n\n<li>Ophthalmology departments</li>\n\n<li>Paramedics</li>\n\n<li>Pharmacists</li>\n\n<li>Phlebotomists</li>\n\n<li>Renal medicine departments</li>\n\n<li>Resuscitation officers and trainers</li>\n\n<li>Risk managers</li>\n\n<li>Supplies managers</li>\n\n<li>Surgeons</li>\n\n<li>Theatre managers</li>\n\n<li>Urology departments</li>\n</ul>\n\n<p><span>Primary care trusts</span><br>\nCAS liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Community dental practices</li>\n\n<li>Community hospitals</li>\n\n<li>Community midwives</li>\n\n<li>Community nurses</li>\n\n<li>Community pharmacists</li>\n\n<li>General dental practitioners</li>\n\n<li>General practitioners</li>\n\n<li>Minor injury units</li>\n\n<li>NHS walk-in centres</li>\n\n<li>Ophthalmic practices</li>\n\n<li>Optometrists</li>\n\n<li>Practice managers</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Care homes providing nursing care</li>\n\n<li>Clinics</li>\n\n<li>Hospitals in the independent sector</li>\n\n<li>Independent treatment centres</li>\n\n<li>Nursing agencies</li>\n</ul>\n\n<p><span>Please note:</span> CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2012/075</span> or <span>2012/010/003/081/016</span></p>\n\n<p><span>Technical aspects</span><br>\nSharon Knight or Louise Mulroy<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;020 3080 7202 / 7344<br>\nFax:&#160;020 8754 3965<br>\nEmail:&#160; <a href=\"mailto:sharon.knight@mhra.gsi.gov.uk\">sharon.knight@mhra.gsi.gov.uk</a> or <a href=\"mailto:louise.mulroy@mhra.gsi.gov.uk\">louise.mulroy@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nJonathan Plumb<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;020 3080 6648<br>\nFax:&#160;020 8754 3965<br>\nEmail:&#160; <a href=\"mailto:jonathan.plumb@mhra.gsi.gov.uk\">jonathan.plumb@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p>Incident Reporting and Investigation Centre<br>\nHealth Facilities Scotland<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)<font class=\"trianglelink\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)</font></a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: All medical devices and medicinal products containing chlorhexidine (MDA/2012/075)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}